Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

In an effort to mitigate the increasing cost of prescription medications

Physicians Finding Ways to Work Around Cost of Rx Medications

0
One physician devised a workaround for EpiPens, which uses an autoinjector filled with epinephrine
For adolescent girls with polycystic ovary syndrome

ENDO: Rx Intervention Restores Normal Ovulation in PCOS

0
Low-dose combo of spironolactone-pioglitazone-metformin linked to 2.5-fold higher ovulation rate
Mylan

Mylan Issues Voluntary Recall of Some EpiPen Auto-Injectors

0
Rare cases of 'failure to activate' spurred the action, company says
Maintenance therapy with cediranib for women with relapsed ovarian cancer is not detrimental to quality of life

Cediranib Tx in Relapsed Ovarian CA Doesn’t Lower Quality of Life

0
Findings among women on maintenance therapy for relapsed ovarian cancer
The incidence of oxybutynin prescription was 27.3 percent among elderly individuals receiving antimuscarinic prescriptions from 2006 to 2012

Oxybutynin Frequently Used for Overactive Bladder in U.S. Elderly

0
Despite known adverse effects, including cognitive decline, oxybutynin most frequently prescribed
From 2010 to 2014 there was an increase in use of diabetes medications

Increased Use of Newer Meds for Diabetic Nephropathy in the U.S.

0
DDP-4 inhibitors used in 54 percent of visits in last quarter of 2014; ACE inhibitors, ARBs often used
For older men

Suicide Risk Not Up With New Rx of 5α-Reductase Inhibitor for BPH

0
But increased risk of self-harm and depression during initial 18 months after initiation of 5α-reductase
Several classes of drugs reduce neuropathy-related pain better than placebo

Review: Several Classes of Drugs Treat Pain of Diabetic Neuropathy

0
Longer-term assessments of outcomes needed, researchers say
For obese or overweight individuals without type 2 diabetes

CANA/PHEN Aids Weight Loss in Obese Without Type 2 Diabetes

0
Canagliflozin plus phentermine superior to placebo for weight loss at 26 weeks in obese, overweight
Prophylactic use of the subcutaneous C1 inhibitor CSL830 is associated with a reduction in the frequency of acute attacks in patients with hereditary angioedema

C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema

0
Subcutaneous CSL830 at doses of 40 and 60 IU reduce rate of attacks, need for rescue medication